(多) -酶结合中的结构-功能关系:直接抑制人类唾液和胰腺α-氨基酶
Rizliya Visvanathan1, Michael J Houghton1, Elizabeth Barber1
1Department of Nutrition, Dietetics and Food, Monash University, BASE Facility, 264 Ferntree Gully Road, Notting Hill, VIC 3168, Australia; Victorian Heart Institute, Monash University, Victorian Heart Hospital, 631 Blackburn Road, Clayton, VIC 3168, Australia.
Food research international (Ottawa, Ont.)
|June 1, 2024
概括
多通过特定的结构特征直接抑制人类的α-氨基酶 (唾液和胰腺). 功能组类型和位置,而不仅仅是基基数,决定了抑制功效.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 营养保健品 营养保健品
背景情况:
- 众所周知,多可以抑制α-氨基酶,这是碳水化合物消化中的关键酶.
- 传统的测定测量直接酶抑制和粉多复合物的形成.
- 使用短寡糖的方法隔离了直接的多-酶相互作用.
研究的目的:
- 研究各种多醇对人类唾液和胰腺α-氨酶的直接抑制的详细结构要求.
- 为了比较50多种多的抑制作用对两个不同的人类α-氨酶异型的抑制作用.
主要方法:
- 使用基于色谱的测定方法,使用一个短的寡糖基质.
- 测试了50多种多来自各种化学群体,包括黄醇,黄和氨酸.
- 分析了直接酶抑制的结构-活性关系.
主要成果:
- 人的唾液和胰腺α-氨基酶,尽管具有高序列同质性,但显示出多醇的差异性抑制.
- 卢特和佩拉戈尼丁是唾液α-氨基酶的强有力的抑制剂.
- 甲氧化氨酸 (peonidin,petunidin) 强烈抑制了胰腺α-氨基酶.
- 特定的结构特征,如C4碳基还原和B环糖化,对每个酶的抑制有不同的影响.
- B环甲氧化增强了这两种酶的抑制;C3和B3'基对唾液α-amylase产生了对抗作用.
结论:
- 聚醇对人类α-胺酶的直接抑制高度依赖于功能组的特定类型和位置.
- 结构特征,而不是基基数量或分子量,是抑制功能的主要决定因素.
- 了解这些结构-活性关系可以为设计更有效的多基抑制剂提供信息.
相关概念视频
Enzyme Inhibition
78.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.3K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Enzymes
81.4K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
81.4K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
554
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
554


